April 21, 2023
We are pleased to announce that GEXVal Inc. is listed in the Japan startup market map launched by JETRO (Japan External Trade Organization).
This is a map collection that describes the Japan venture ecosystem of 11 markets created by JETRO to bridge and promote the business between international investors and promising Japanese startups.
GEXVal is listed under the ‘Rare Diseases’ category of the Drug Discovery (‘Medical Supplies’) in the MAP of Life Sciences Market'.
“We are proud to be the front runner in our category, as the Ph1 study of our lead pipeline is progressing well”, says Nobuaki Hirashima, our Chief Business Officer.
The market map is available at the link below.
GEXVal Inc. is striving to address unmet medical needs in rare diseases and deliver innovative medicine to patients and their families who are awaiting better treatment options.
JETRO (Japan External Trade Organization) is a government organization with a mission to promote trade and investment between Japan and the rest of the world.
For further information, please contact us: email@example.com